In this study, we analyzed the relationship between MYD88 L265P mutation and the clinical features of DLBCL patients except for CNS DLBCL and primary cutaneous DLBCL, leg type, because these two subtypes are clinically different from other DLBCL patients. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.